
Propel Bio Management, LLC is a Sector-focused Hedge Fund based in Los Angeles, CA led by Leen Kawas, reporting $131.4M in AUM as of Q3 2025 with 74% Healthcare concentration, 87% concentrated in top 10 holdings, and 23% allocation to PAGP.
Largest long holdings in Propel Bio Management, LLC's portfolio (87.1% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Oil & Gas Midstream Energy | $23.2M | 23.23% | — | 0.64% 1.3M shares | |
Biotechnology Healthcare | $11.9M | 11.94% | -$7.5M Sold | 7.41% 3.8M shares | |
Biotechnology Healthcare | $10.9M | 10.88% | — | 0.29% 228.9K shares | |
Biotechnology Healthcare | $10.2M | 10.26% | +$6.7M Bought | 6.03% 5.1M shares | |
Biotechnology Healthcare | $6.8M | 6.83% | — | 7.84% 11.3M shares | |
Biotechnology Healthcare | $6.5M | 6.51% | -$4.4M Sold | 0.78% 552.9K shares | |
Biotechnology Healthcare | $5.1M | 5.15% | — | 1.90% 974.0K shares | |
Medical - Specialties Healthcare | $4.7M | 4.72% | +$2.3M Bought | 1.25% 438.5K shares | |
Biotechnology Healthcare | $4.0M | 4.01% | +$4.0M New | 0.23% 155.0K shares | |
Biotechnology Healthcare | $3.5M | 3.52% | -$281.8K Sold | 3.41% 1.9M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Propel Bio Management, LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
New | |
+186.06% |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
-40.09% | |
-38.46% | |
-7.42% |
Portfolio insights and performance metrics for Propel Bio Management, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.